While biotech startups showcased their innovative research at a conference, the financial landscape remains challenging. However, panelists emphasized the potential for stability and growth in Europe as an attractive investment opportunity. The establishment of the European Life Sciences Coalition further underscores this shift, suggesting a move towards more localized funding within the continent. As the biotech industry continues to evolve, it will be crucial to monitor funding trends and inve...